Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2023 was 51.08% (a -35.82% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -24.34%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 96.19% (a -68.86% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 308.88% (a 15.95% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 266.38% (a -466.36% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2023 was 70.76% (a -19.03% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -33.83% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
---|---|---|---|
70.76% | 87.39% | 96.19% | 106.93% |
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Design Therapeutics, Inc.
Most recent Research and Development (R&D) Expenses Growthof DSGN including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Design Therapeutics, Inc.
Design Therapeutics, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | 51.08% | 79.59% | – | – | – |
2022 | 94.29% | 67.51% | 124.69% | 126.04% | 96.19% |
2021 | 170.94% | 346.13% | 373.8% | 927.85% | 308.88% |
2020 | -62.67% | -77.52% | -78.89% | -90.27% | 266.38% |
2019 | – | – | – | – | -72.71% |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology